NDC Product
Glycophos NDC 63323-241
- Generic Name
- N/A
- Dosage Form
- N/A
- Route
- N/A
- Marketing
- UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
Excluded / Inactive
The following National Drug Codes (NDCs) are directly associated with the clinical concept for Sodium glycerophosphate 4.32 GM (sodium 40 mmol, phosphate 20 mmol) in 20 mL Injection (RxCUI 1423807). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.
Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.